What is CRISPR?

Imagine a huge recipe book in a busy kitchen. It runs to three billion letters, and it tells the cook how to make every dish in the house. One line has a spelling mistake. That one line spoils a dish the family eats every single day.

You want to fix that line. You do not want to reprint the book. You want to find the page, cut out the wrong word, and set it right.

CRISPR is the tool that does this inside living cells. The book is DNA. The mistake is a faulty gene. CRISPR finds the line and cuts it.

What CRISPR actually is

CRISPR is a way to edit DNA at a chosen spot. The name is short for a long phrase about repeating patterns in bacterial DNA. The name matters far less than the two parts.

The first part is a guide. It is a short strand of RNA, written by the scientist to match the target line of DNA. The second part is a protein that cuts DNA. The best known one is called Cas9.

Stop on the word guide, because it holds the whole story. Scientists could already cut DNA before CRISPR. Aiming the cut was the slow and costly step. CRISPR made aiming cheap, because writing a fresh guide takes very little work.

How it works, step by step

1. Scientists pick the exact stretch of DNA they want to change.
2. They write a guide strand that matches that stretch.
3. The guide and the cutting protein go into the cell together.
4. The guide searches along the DNA until it finds its match.
5. The protein cuts both strands of the DNA at that point.
6. The cell repairs the cut, and the repair is where the real change happens.

That last step deserves attention. THE CELL DOES THE EDITING. A rushed repair usually spoils the gene, and that is how a gene is switched off. If scientists supply a matching template, the cell can copy it in, and that is how a new sequence is written.

Where it came from

CRISPR was not designed by anyone. It was found.

Bacteria are attacked by viruses too. Over time, some bacteria began keeping short pieces of virus DNA as a record of past attacks. When the same virus returns, the bacterium makes a guide from that record and cuts the invader apart.

In other words, this is a bacterial immune system. Researchers worked out how to write their own guides for it, and then aimed it at whatever they liked. The work won a Nobel Prize in chemistry in 2020.

What it is good at

CRISPR is cheap, quick and easy to aim. A lab that once changed one gene in a year can now test many in a month. That single shift explains most of the excitement around it.

It also works in nearly every living thing. Bacteria, plants, insects, fish and human cells all use the same four-letter code, so one tool serves all of them.

It is best of all at switching a gene off. That is the simplest edit, and it is the one used most in research. If you want to learn what a gene does, break it and watch what changes.

What it is bad at

Aiming is good, yet it is not perfect. A guide can stick to a stretch of DNA that is nearly the same as the target. The cut then lands in the wrong place. These off-target edits are the main safety worry, and labs test for them with care.

Delivery is the harder problem. Editing cells in a dish is routine work. Getting the tool into the right cells inside a living body is not. Blood, eye and liver cells can be reached today. Many other tissues cannot.

Writing a long new sequence is still difficult as well. Breaking a gene is easy. Putting a corrected copy in its place is much harder, and it works well in only some cell types.

Body cells and inherited changes

There is a line here that is worth learning.

An edit to ordinary body cells affects one patient and stops there. It is not passed to their children. Almost all medical work sits on this side of the line.

An edit to an embryo, an egg or a sperm cell is a different matter. It would be copied into every cell of that person, and then passed down the family. Most countries forbid this in pregnancies, and the medical world treats it as off limits for now.

The same hard question sits under other body technologies. A brain-computer interface raises it as well. Who agrees to a permanent change, and on whose behalf?

Where you already meet it

The first CRISPR medicine has already reached patients. In late 2023, regulators in the United Kingdom and then the United States approved a treatment for sickle cell disease and a related blood disorder. Doctors take blood stem cells out of the patient, edit them, and return them.

This matters well beyond the clinic. Sickle cell disease is most common in West and Central Africa. More babies are born with it in Nigeria than in any other country on earth.

Yet the price today is measured in millions per person. The treatment also needs a hospital that can carry out a stem cell transplant safely. Therefore the next problem to solve is cost and delivery, and that problem is as much about health systems as about science.

CRISPR is used outside medicine too. Crops have been edited for disease resistance and longer shelf life. Simple field tests that spot a virus by its genetic code borrow the same searching trick.

What to watch next

Two changes are worth following.

The first is precision. Newer methods can change a single letter, or write a short passage, without cutting both strands of the DNA. They are called base editing and prime editing. They cause fewer unwanted breaks, and they are slower to reach patients.

The second is delivery. If a tiny bubble of fat can carry the tool to the right organ by injection, the price falls and the hospital requirement falls with it. That is the change that would bring gene editing into ordinary clinics.

Keep one habit when you read gene editing news. Ask whether the story is about cells in a dish, an animal, or a person in a trial. Those three stages are years apart. The same test works on headlines about a brain-computer interface, and it will save you a lot of disappointment.

Just Out Tech explains new research in plain language. This article was drafted with AI assistance and checked by a human against the original source.